ArticleNPJ science of food2026
Preparation, allergenicity analysis and nutritional evaluation of partially and extensively hydrolyzed whey protein peptides.
Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
With the growing focus on health, investigating the potential benefits of whey protein peptides for musculoskeletal health is essential. This study employed enzymatic hydrolysis to prepare concentrated whey protein peptides. The results indicated that optimal conditions for partially hydrolyzed peptides were achieved using alcalase (1500 U/g for 0.5 h), while extensive hydrolysis was produced using alcalase and flavourzyme (3000 U/g, 1:1 ratio for 2.0 h). Post-hydrolysis, there was no amino acid loss, and branched-chain amino acid content increased by 56.68 mg/g; allergenicity of α-LA and β-LG decreased by 90.73% and 70.48%, respectively; treatment of Caco-2 cells with hydrolyzed peptides at 0.5-2.5 mg/mL for 24 h showed cell viability over 100% relative to controls, indicating non-cytotoxicity; the highest calcium transport efficiencies were 5.38 μg/well and 8.62 μg/well at 2.5 mg/mL. This study provides theoretical and technical support for hypoallergenic functional foods targeting musculoskeletal health.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.